118 related articles for article (PubMed ID: 16982886)
1. Ligation of CD80 is critical for high-level CD25 expression on CD8+ T lymphocytes.
Pejawar-Gaddy S; Alexander-Miller MA
J Immunol; 2006 Oct; 177(7):4495-502. PubMed ID: 16982886
[TBL] [Abstract][Full Text] [Related]
2. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
3. CD86 has sustained costimulatory effects on CD8 T cells.
Thomas IJ; Petrich de Marquesini LG; Ravanan R; Smith RM; Guerder S; Flavell RA; Wraith DC; Wen L; Wong FS
J Immunol; 2007 Nov; 179(9):5936-46. PubMed ID: 17947667
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry.
Thiel M; Wolfs MJ; Bauer S; Wenning AS; Burckhart T; Schwarz EC; Scott AM; Renner C; Hoth M
Immunology; 2010 Jan; 129(1):28-40. PubMed ID: 19824921
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.
Bak SP; Barnkob MS; Bai A; Higham EM; Wittrup KD; Chen J
J Immunol; 2012 Aug; 189(4):1708-16. PubMed ID: 22798683
[TBL] [Abstract][Full Text] [Related]
6. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
7. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
8. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation.
Mark DA; Donovan CE; De Sanctis GT; Krinzman SJ; Kobzik L; Linsley PS; Sayegh MH; Lederer J; Perkins DL; Finn PW
Int Immunol; 1998 Nov; 10(11):1647-55. PubMed ID: 9846693
[TBL] [Abstract][Full Text] [Related]
9. Cowpox virus encodes a protein that binds B7.1 and B7.2 and subverts T cell costimulation.
Wang X; Piersma SJ; Elliott JI; Errico JM; Gainey MD; Yang L; Nelson CA; Yokoyama WM; Fremont DH
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21113-21119. PubMed ID: 31575740
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.
Puliaeva I; Soloviova K; Puliaiev M; Lang T; Puliaev R; Via CS
J Immunol; 2011 Jan; 186(1):291-304. PubMed ID: 21115734
[TBL] [Abstract][Full Text] [Related]
11. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Arens R; Flynn R; Sette A; Schoenberger SP; Croft M
J Immunol; 2009 Mar; 182(5):2909-18. PubMed ID: 19234186
[TBL] [Abstract][Full Text] [Related]
12. The role of intercellular adhesion molecule-1/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses.
Jenkinson SR; Williams NA; Morgan DJ
J Immunol; 2005 Mar; 174(6):3401-7. PubMed ID: 15749873
[TBL] [Abstract][Full Text] [Related]
13. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
[TBL] [Abstract][Full Text] [Related]
14. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
[TBL] [Abstract][Full Text] [Related]
15. Regulating the expression of CD80/CD86 on dendritic cells to induce immune tolerance after xeno-islet transplantation.
Ke N; Su A; Huang W; Szatmary P; Zhang Z
Immunobiology; 2016 Jul; 221(7):803-12. PubMed ID: 26879762
[TBL] [Abstract][Full Text] [Related]
16. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
17. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
18. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
Fuse S; Zhang W; Usherwood EJ
J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
[TBL] [Abstract][Full Text] [Related]
19. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
[TBL] [Abstract][Full Text] [Related]
20. Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.
Olsson C; Michaëlsson E; Parra E; Pettersson U; Lando PA; Dohlsten M
Int Immunol; 1998 Apr; 10(4):499-506. PubMed ID: 9620606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
